Protein and Peptide Therapeutics and Forecast Market

List of Tables
Table 1. Protein and Peptide Therapeutics Market Opportunities & Trends in Global Market
Table 2. Protein and Peptide Therapeutics Market Drivers in Global Market
Table 3. Protein and Peptide Therapeutics Market Restraints in Global Market
Table 4. Key Players of Protein and Peptide Therapeutics in Global Market
Table 5. Top Protein and Peptide Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Protein and Peptide Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Protein and Peptide Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Protein and Peptide Therapeutics Product Type
Table 9. List of Global Tier 1 Protein and Peptide Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Protein and Peptide Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Protein and Peptide Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Protein and Peptide Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Protein and Peptide Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Protein and Peptide Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Protein and Peptide Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Protein and Peptide Therapeutics Product Offerings
Table 32. Sanofi Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Teva Corporate Summary
Table 34. Teva Protein and Peptide Therapeutics Product Offerings
Table 35. Teva Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Novo Nordisk Corporate Summary
Table 37. Novo Nordisk Protein and Peptide Therapeutics Product Offerings
Table 38. Novo Nordisk Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Takeda Corporate Summary
Table 40. Takeda Protein and Peptide Therapeutics Product Offerings
Table 41. Takeda Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Eli Lilly Corporate Summary
Table 43. Eli Lilly Protein and Peptide Therapeutics Product Offerings
Table 44. Eli Lilly Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Protein and Peptide Therapeutics Product Offerings
Table 47. AstraZeneca Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Protein and Peptide Therapeutics Product Offerings
Table 50. Novartis Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. AbbVie Corporate Summary
Table 52. AbbVie Protein and Peptide Therapeutics Product Offerings
Table 53. AbbVie Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Ipsen Corporate Summary
Table 55. Ipsen Protein and Peptide Therapeutics Product Offerings
Table 56. Ipsen Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Ferring Corporate Summary
Table 58. Ferring Protein and Peptide Therapeutics Product Offerings
Table 59. Ferring Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Merck Corporate Summary
Table 61. Merck Protein and Peptide Therapeutics Product Offerings
Table 62. Merck Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. The Medicines Corporate Summary
Table 64. The Medicines Protein and Peptide Therapeutics Product Offerings
Table 65. The Medicines Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. J & J Corporate Summary
Table 67. J & J Protein and Peptide Therapeutics Product Offerings
Table 68. J & J Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Protein and Peptide Therapeutics Segment by Type in 2021
Figure 2. Protein and Peptide Therapeutics Segment by Application in 2021
Figure 3. Global Protein and Peptide Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Protein and Peptide Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Protein and Peptide Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Protein and Peptide Therapeutics Revenue in 2021
Figure 8. By Type - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novo Nordisk Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Takeda Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eli Lilly Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AbbVie Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Ipsen Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Ferring Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Merck Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. The Medicines Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. J & J Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)